The Lancet Haematology · 2023 · 150 citations · 26 references
MedicineInternal MedicineOncologyImmunotherapyHematologic Malignancy TherapyMinimal Residual DiseaseMultiple MyelomaResponse AssessmentTherapy Response AssessmentMinimal Residual Disease - Directed TherapyMinimal Residual Disease TargetingMinimal Residual Disease-guided TherapyMultiple Myeloma TherapyMultiple Myeloma TreatmentRelapsed Multiple Myeloma
26
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
Michel Attal, Valérie Lauwers‐Cancès, Cyrille Hulin et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Michel Attal, Valérie Lauwers‐Cancès, Gérald Marit et al. · New England Journal of Medicine · 2012 · 1.2K citations · Full text
Medicine, Oncology, Pharmacotherapy +13
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text